Target intelligence / Profile preview

TPT1 pseudogene 14 (TPT1P14)

Target: TPT1P14
Molecular classification: Other

Overview

TPT1 pseudogene 14 (TPT1P14) is a processed pseudogene of the tumor protein, translationally-controlled 1 (TPT1) gene. As a pseudogene, TPT1P14 is a non-functional segment of DNA resembling the parent TPT1 gene but does not encode an active protein or participate in cellular pathways. Pseudogenes arise via reverse-transcription and integration of parental gene mRNA and are generally considered non-coding elements in the genome. There is no evidence that TPT1 pseudogene 14 acts as a receptor, enzyme, transporter, or is otherwise considered a classic therapeutic target in pharmacology or drug development.

Other names: TPT1P14

Beyond the preview

Go deeper on TPT1 pseudogene 14 (TPT1P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPT1 pseudogene 14 (TPT1P14).

Explore the full profile